Modeling and gene therapy of dysferlinopathy cause various types of primary dysferlinopathies, which include
Miyoshi myopathy (MM), Limb
Twenty-year clinical progression of dysferlinopathy in patients from DagestanUmakhanova Z.,
Bardakov S.,
Mavlikeev M.,
Chernova O.,
Magomedova R.,
Akhmedova P.,
Yakovlev I.,
Dalgatov G.,
Fedotov V.,
Isaev A.,
Deev R. ranging from 1:1,300 to 1:200,000 in different populations. In 1996, Dr. S.
N. Illarioshkin described a
Twenty-year clinical progression of dysferlinopathy in patients from DagestanUmakhanova Z.,
Bardakov S.,
Mavlikeev M.,
Chernova O.,
Magomedova R.,
Akhmedova P.,
Yakovlev I.,
Dalgatov G.,
Fedotov V.,
Isaev A.,
Deev R. ranging from 1:1,300 to 1:200,000 in different populations. In 1996, Dr. S.
N. Illarioshkin described a
Modeling and gene therapy of dysferlinopathy cause various types of primary dysferlinopathies, which include
Miyoshi myopathy (MM), Limb